WednesdayDec 28, 2022 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Continues to See Growth in Patient Enrollment for Brain Cancer Drug Candidate Global Clinical Trial

CNS Pharmaceuticals is conducting a potentially pivotal clinical trial in the United States and Europe to establish the effectiveness of a drug candidate for combating incurable glioblastoma (“GBM”) brain cancers CNS’s flagship drug candidate is called Berubicin, a product initially developed by another company with encouraging small-population results in 2006, and CNS is expanding the testing with expectations of eventually delivering an innovative new GBM treatment to market The company aims to enroll more than 200 patients in its global Berubicin trial on a 2:1 randomization schema comparing Berubicin-treated patients to those receiving second-line standard of care chemotherapy agent lomustine…

Continue Reading

WednesdayDec 28, 2022 9:00 am

M&A Activity Keeps Flora Growth Corp. (NASDAQ: FLGC) Revenues Strong Amid Expected Rebound in Cannabis Industry

Cannabis cultivator and international brand developer Flora Growth has continued to build its revenues through accretive acquisitions during the past year and expects to see revenues continue to rise amid further M&A activity Flora expects to lock in its latest acquisition by the end of the month after shareholders meet to discuss the proposed deal with multi-national operator Franchise Global Health (“FGH”), which would grant Flora immediate access to Germany’s cannabis market and FGH the ability to overcome supply chain difficulties Flora has previously reported cooperative agreements that increase its product distribution pipeline in Europe through Switzerland and the Czech…

Continue Reading

TuesdayDec 27, 2022 1:39 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes on Acquisition of Multinational Medical Cannabis Operator

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has completed a “plan of arrangement,” or acquisition, of Franchise Global Health Inc. (TSX.V: FGH), a multinational operator in the medical cannabis and pharmaceutical industry with principal operations in Germany. Shareholders of Global Health Inc. approved the plan, which was effective as of Dec. 23, 2022. FLGC anticipates that the acquisition will provide a direct connection between Flora Growth’s Colombian-grown cannabis and German-based pharmaceutical and medical cannabis distribution. The company also noted that the acquisition will establish a foothold in Germany for medical cannabis…

Continue Reading

TuesdayDec 27, 2022 1:23 pm

QualityStocksNewsBreaks – CubCrafters Inc. Featured in AVweb Article

CubCrafters was featured in a recent article published by AVweb, the world’s premier independent aviation news resource. The piece, written by Mark Phelps, delves into CubCrafters’ recent strategic acquisition. “Just in time for ski season, backcountry aircraft icon CubCrafters is showing its fiscal savvy by acquiring Summit Aircraft Skis. The manufacturer of Part 23-certified, light-sport and experimental aircraft bought the design and manufacturing assets, unique patents and related intellectual property of Sandpoint, Idaho-based Summit Aircraft Skis, which are ‘favored by [CubCrafters’] Carbon Cub aircraft owners and preferred by the owners of many other types of non-CubCrafters manufactured backcountry capable aircraft,’…

Continue Reading

TuesdayDec 27, 2022 1:11 pm

QualityStocksNewsBreaks – SideChannel Inc.’s (SDCH) Innovative Segmentation Solution Featured in TechDecisions Article

SideChannel (OTCQB: SDCH) was featured in a recent article published by TechDecisions. The piece highlights SideChannel’s launch of the Enclave microsegmentation platform, which offers small to mid-sized businesses (“SMBs”) a solution to simplify and maintain a segmented network with minimal IT administration and maintenance. Enclave is designed to enable IT personnel to easily segment their company’s network, quickly organize individuals and machines to each individual’s workload level, then implement security controls across all segments. “Small and mid-market companies are incredibly challenged by a lack of cost-effective means to comfortably and securely handle network management,” one of the lead developers behind…

Continue Reading

TuesdayDec 27, 2022 1:02 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Looks for Strong Numbers in Upcoming Quarter

FingerMotion (NASDAQ: FNGR), a mobile data and services company, is anticipating more than $10 million in quarter revenues for the period ended Nov. 30, 2022. The company announced that, based on expected revenue growth in its core businesses, the company also projects that 2022 annual revenue will exceed last year’s total. The company explained the projections by noting that, during the past six months, FingerMotion has raised a total of $15.5 million in proceeds from a convertible note private placement and a nonbrokered private placement offering. By Nov. 30, 2022, only a portion of the funds raised was used, leaving…

Continue Reading

TuesdayDec 27, 2022 12:23 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast, Secures New Contracts Spanning Multiple States

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release highlights Knightscope’s recent securement of its largest single contract to date alongside two new contracts from cities in New York and Georgia. “Knightscope continues to deliver on its promise to rapidly grow the company and help make the United States of America the safest country in the world,” William Santana Li, chairman and CEO of Knightscope,…

Continue Reading

TuesdayDec 27, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability in Pharmaceuticals

Studies have indicated that around 40% of the available drugs on the market offer poor bioavailability Lexaria’s patented DehydraTECH(TM) technology increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery The global pharmaceutical drug delivery market was valued at $1.66 billion in 2021 and is expected to grow at a CAGR of 5.9%, resulting in a value of $2.21 billion by 2026 One of the main concerns associated with marketed drugs is low bioavailability. Bioavailability is the amount of a drug or substance that becomes completely available to the intended biological destination…

Continue Reading

TuesdayDec 27, 2022 11:53 am

QualityStocksNewsBreaks – Vision Energy Corp. (VENG) Increases Core Team to Realize Project Development Objectives

Vision Energy (OTCQB: VENG) today provided an update on the expansion of its project management and development team. According to the announcement, Vision Energy, through its wholly owned Dutch subsidiary Evolution Terminals BV (“ETBV”), continues work to realize its project development objectives and has increased its core team of experienced commercial and engineering professionals. Since its December 2020 incorporation, ETBV has been executing its mission to design and develop a pioneering Green Energy Hub for renewable products, hydrogen carriers and low-carbon fuels. In March 2021, ETBV engaged professionals from Rotterdam-based Riverlake Solutions, a specialist project development and engineering consultancy to…

Continue Reading

TuesdayDec 27, 2022 11:15 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Eyes Entry into Grid-Tied Applications; Continues Development of Its Enhanced Powertrain Solution

Hillcrest is poised to accelerate its efforts to expand into grid-tied applications to help diversify future revenue streams; continues development of its Enhanced Powertrain Solution to bridge the gap between EVs and universal, bidirectional charging systems Its unique application-agnostic ZVS inverter technology allows the company to quickly adapt its technology to any motor or grid application, setting it up for entry into renewable energy generation and storage, as well as e-mobility charging Hillcrest’s Enhanced Powertrain Solution is expected to simplify the overall EV powertrain and charging system and free EVs from the need for an onboard charger or additional onboard…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered